Kidney International Reports

Article	Citations
Epigenome-Wide Association Studies of DNA Methylation in Kidney Diseases	156
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis	150
Association Between Maternal Smoking, Isolated Proteinuria During Pregnancy and Preterm Birth: A Finnish Registry Analysis	118
Longitudinal Changes in Kidney Solute Clearance in a Prospective Cohort of Patients Initiating Chronic Hemodialysis	114
Pregnancy and Family Planning in Women With Kidney Disease	93
Genetically Predicted Body Selenium Concentration and estimated GFR: A Mendelian Randomization Study	77
SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination	73
Torque Teno Virus-Guided Immunosuppression in Kidney Transplantation: Expanding the Application	72
Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants	66
Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation	60
POS-253 THE RELATIONSHIP BETWEEN THE NEUTROPHILS / LYMPHOCYTES RATIO AND THE PLATELETS / LYMPHOCYTES RATIO WITH THE OCCURRENCE OF CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS PATIENTS	59
POS-260 Polycystic kidney disease in Chad: about 26 cases	55
POS-336 SEMAGLUTIDE 2.4 MG AND 1.0 MG IMPROVED ALBUMINURIA IN ADULTS WITH OVERWEIGHT/OBESITY AND TYPE 2 DIABETES IN STEP 2	54
POS-640 MACHINE LEARNING FOR INTRADIALYTIC HYPOTENSION PREDICTION IN HAEMODIALYSIS PATIENTS	52
POS-206 Subphenotyping using combined biomarkers and clinical data reveals novel patterns within high-risk patients with diabetic kidney disease	52
POS-466 THE CRITICAL ROLE OF A NEPHROLOGIST IN KIDNEY STONES: A TALE OF PRIMARY HYPEROXALURIA	52
POS-001 Mitochondrial enzymes infused into the kidney under hydrodynamic pressures significantly improves creatinine and BUN levels at the onset of moderate and severe acute kidney injuries	51
POS-140 DEVELOPMENT OF CHRONIC KIDNEY DISEASE FROM SNAKE BITE INDUCED ACUTE KIDNEY INJURY- RISK ASSESSMENT	48
POS-672 EFFLUENT PERITONEAL DIALYSIS FLUID TURBIDITY CAN REVEAL COLON CANCER	48
POS-837 PARATHYROIDECTOMY IS ASSOCIATED WITH SLOW PROGRESSION OF VASCULAR CALCIFICATION IN MAINTENANCE HEMODIALYSIS PATIENTS: A PROPENSITY SCORE-MATCHED CASE-CONTROL STUDY	48
POS-630 RELIABILITY OF NEPHROLOGIST LED CLINICAL ASSESSMENT FOR VASCULAR ACCESS CREATION	47
POS-087 MINERAL BONE DISORDERS IN CHILDREN WITH SICKLE CELL ANEMIA AND ACUTE KIDNEY INJURY	47
WCN23-0159 ENPP6 IS A POTENTIAL NOVEL CANDIDATE GENE FOR MONOGENIC CONGENITAL ANOMALIES OF THE KIDNEYS AND URINARY TRACT	45
POS-014 NEPHROLOGY REFERRAL PATTERN AND SHORT-TERM OUTCOMES IN COVID 19 POSITIVE PATIENTS	45
POS-003 The three C-terminal domains of FHR1 influence complement activation and FHR1 cooperation with other complement regulators	44

WCN23-0567 PERTURBATIONS IN FREQUENCY AND FUNCTION OF CLASSICAL AND EXHAUSTED MEMORY B CELLS IN LUPUS NEPHRITIS	42
WCN23-1039 THE XGBckd MODEL: PREDICT CHRONIC KIDNEY DISEASE IN DIABETES PATIENTS	41
WCN23-1170 ASSOCIATION OF ANGIOTENSINOGEN GENE POLYMORPHISM WITH NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS OF BANGLADESH	41
POS-245 THROMBOMODULIN ACTIVATION DRIVEN BY LIVER X RECEPTOR AGONIST T0901317 ATTENUATES RENAL INFLAMMATION IN DIABETIC NEPHROPATHY	40
POS-133 CASE REPORT OF DISSEMINATED KLEBSIELLA INFECTION IN T2DM LEADING TO CKD	40
WCN23-0378 STUDY OF CLINICAL OUTCOME AND FOLLOW-UP OF MALE LUPUS NEPHRITIS IN A TERTIARY CARE CENTER	40
WCN23-0726 UREA REDUCTION IN ACUTE KIDNEY INJURY AND MORTALITY RISK	40
POS-562 A NEW MANAGEMENT METHOD OF METABOLISM OF MINERAL AND BONE FOUNDING BY MACHINE LEARNING IN HEMODIALYSIS PATIENTS	39
WCN23-0285 Acute Kidney Disease in the Outpatient Setting: A Hidden Burden Detected by the Integrated National and Institutional Electronic Medical Records Exchange Platform	39
WCN23-1177 Practice patterns of Chronic Kidney Disease Screening and Monitoring in Brazil: A Nationwide Laboratory-based Analysis	39
POS-691 CLINICAL OUTCOME OF PERITONEAL DIALYSIS CATHETER REMOVAL AND REINSERTION VIA MODIFIED SELDINGER TECHNIQUE ' THE SERDANG-UPM METHOD'	38
POS-834 SPONTANEOUS RESOLUTION OF LARGE PERICARDIAL EFFUSION AFTER CARDIOPULMONARY RESUSCITATION IN A CHRONIC KIDNEY DISEASE PATIENT ON MAINTENANCE HAEMODIALYSIS	38
POS-008 EXTRARENAL MANIFESTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: CARDIAC AND LUNG INVOLVEMENT	37
WCN23-1059 OUTCOME OF ATYPICAL HEMOLYTIC UREMIC SYNDROME IN ADULT : A SINGLE CENTER STUDY IN TAIWAN	36
POS-912 EFFECTIVENESS OF SARS-COV 2 VACCINATION IN KIDNEY TRANSPLANT PATIENTS IN CHILE	36
POS-830 DEMOGRPAHICS AND LONG-TERM OUTCOMES OF CHILDREN WITH END-STAGE KIDNEY DISEASE: A 20-YEAR TERRITORY-WIDE STUDY	36
WCN23-0258 SHORT-CHAIN FATTY ACIDS DIRECTLY EXERT ANTI-INFLAMMATORY RESPONSES IN PODOCYTES AND TUBULAR EPITHELIAL CELLS EXPOSED TO HIGH GLUCOSE	36
WCN23-0905 SYSTEMATIC MICROBIOME DYSBIOSIS ARE ASSOCIATED WITH IGA NEPHROPATHY	36
POS-018 PHASE CONTRAST MAGNETIC RESONANCE IMAGING TO ASSESS RENAL PERFUSION IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	35
POS-263 SEXUAL DISORDERS IN PATIENTS WITH CHRONIC RENAL FAILURE	35
WCN23-0212 LIRAGLUTIDE IMPROVES BOTH DIABETIC NEPHROPATHY AND CARDIOMYOPATHY IN THE SDT FATTY RAT, A CARDIORENAL MODEL OF TYPE 2 DIABETES	35
POS-484 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME: AN UNDERRECOGNIZED MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS	34
POS-036 A YOUNG FEMALE WITH RENAL CORTICAL NECROSIS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN IN A RESOURCE POOR SETTING: CASE REPORT	34
POS-072 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR (2017-2020)	33
WCN23-0687 CHANGES OF MEDICAL COSTS AND NUMBER OF USES FOR CONTINUOUS RENAL REPLACEMENT THERAPY UNTIL RECENT SIX YEARS IN SOUTH KOREA	33
POS-065 DISSEMINATED TUBERCULOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RARE PRESENTATION AS A PULMONARY-RENAL SYNDROME	33
WCN23-1106 POLYOMAVIRUS TYPE BK-ASSOCIATED NEPHROPATHY IN A NON-KIDNEY TRANSPLANT RECIPIENT	32
WCN23-0138 Can a Kidney Failure Patient survive with one to two hemodialysis sessions per month for more than 5 years?	32
WCN23-1008 PAEDIATRIC RENAL TRANSPLANTATION : EXPERIENCE OF A CENTER	32
WCN23-0435 UREMIC PERICARDITIS IN CHRONIC END-STAGE RENAL DISEASE: EXPERIENCE OF THE IBN ROCHD UNIVERSITY HOSPITAL	32
POS-074 Recurrent subcutaneous Phaeohyphomycosis with bone involvement after kidney transplant: A case report	31
WCN23-0377 THE ROLE OF INTRA-CATHETER TAUROLIDINE IN PREVENTING RELAPSING AND REPEAT PERITONEAL DIALYSIS-RELATED PERITONITIS	31
POS-084 OUTCOMES OF BIOPSY PROVEN BKV NEPHROPATHY POST KIDNEY TRANSPLANT – A SINGLE CENTRE EXPERIENCE	31
POS-240 CGAS/STING DECREATES RENAL FIBROSIS AND INFLAMMATORY RESPONSE INDUCED BY HYPERTENSION BY REGULATING GLUTATHINE METABOLISN	30
WCN23-0894 APPLICATION OF KDQOL SF- V 1.3 IN OLDER PATIENTS WHO MADE PREVALENT HEMODIALYSIS	30
WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY	30
POS-328 SUPPRESSION OF ER-ASSOCIATED DEGRADATION BY INTRAGLOMERULAR CROSS-COMMUNICATION BETWEEN MESANGIAL CELLS AND PODOCYTES CAUSES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE	29
POS-216 OUTCOME AMONG ELDERLY WITH ADVANCED KIDNEY DISEASE MANAGED NON-DIALYSIS VERSUS DIALYSIS. A SINGLE CENTRE EXPERIENCE	29
WCN23-0355 A SEASON OF ACUTE KIDNEY INJURY POST BREAST AUGMENTATION	29
POS-611 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR	29
POS-321 A RARE NON DIABETIC GLOMERULAR DISEASE IN DIABETIC	29
POS-605 THE RELEVANCE OF A GERIATRIC ASSESSMENT IN ELDERLY HEMODIALYSIS PATIENTS	29
POS-125 PERSISTENT MACROSCOPIC HAEMATURIA IN SYSTEMIC ERYTHEMATOSUS	28
POS-123 Determinants of Outcome in Crescentic Glomerulonephritis: A Retrospective Study of 78 patients from Tunisia, North Africa	28
POS-429 HYPERTENSION IN TUNISIAN ADULTS WITH POLYCYSTIC KIDNEY DISEASE : A RETROSPECTIVE COHORT OF 74 CASES	27
WCN23-0582 ECULIZUMAB FOR BEVACIZUMAB-INDUCED THROMBOTIC MICROANGIOPATHY	27
WCN23-0525 A new therapeutic strategy in severe IgA nephropathy by MP pulse and SVF	27
POS-402 UNCOUPLING PROTEIN 1 (UCP1) INHIBITS EPITHELIAL MESENCHYMAL TRANSFORMATION AND EXTRACELLULAR MATRIX AGGREGATION IN RENAL INTERSTITIAL FIBROSIS THROUGH SIRT3 DEPENDENT REACTIVE OXYGEN SPECIES (	27
POS-628 COMPARISON OF CITRATE ANTICOAGULATION STRAGEGIES IN HEMODIALYSIS PATIENTS AT HIGH RISK OF BLEEDING: A MUTICENTER PROSPECTIVE OBSERVATIONAL COHORT STUDY	26
POS-439 The PROPKD score affect renal involvement in patients with tolvaptan-treated autosomal dominant polycystic kidney disease ?	26

WCN23-0334 VITAMIN D LEVEL IN SLE PATIENTS WITH OR WITHOUT RENAL INVOLVEMENT AND IT’S RELATIONSHIP WITH DISEASE ACTIVITY (SLEDAI SCORE)	25
Anti-Rituximab Antibodies in Primary Membranous Nephropathy: Time for Routine Monitoring in Clinical Practice?	25
Addressing the Multisystemic Impacts of Nephropathic Cystinosis in an Adult	25
Belatacept Conversion in Adolescent Kidney Transplant Recipients: A Solution for the Critical Challenge of Adherence?	25
Association of Pulmonary Hypertension With Outcomes in Kidney Transplant Recipients	25
Navigating Complex Relationships Between Perioperative Hypotension and Delayed Graft Function in Kidney Transplantation	25
Program Implementation to Achieve Sustainability for Early Detecting of Kidney Diseases and Promoting Kidney Health and Transplantation in Communities	25
Errata	25
WCN24-1742 TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?	24
WCN24-707 QUALITY OF LIFE IN HEMODIALYSIS PATIENTS IN BOLIVIA	24
WCN24-2446 EVALUATION OF DISEASE MANAGEMENT AND SELF-CARE NEEDS IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE	24
WCN24-1112 ASSESSMENT AND COMPARISON OF THE QUALITY OF LIFE OF BRAZILIAN AND VENEZUELAN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS TREATMENT IN RORAIMA-BRAZIL	24
WCN24-1498 CHARACTERISTICS OF ADMISSION TO HEMODIALYSIS OF THE PATIENT WITH CHRONIC KIDNEY DISEASE IN SANTA CRUZ-BOLIVIA: A DESCRIPTIVE AND ANALYTICAL OBSERVATIONAL MULTICENTER CROSS-SECTIONAL STUDY	24
WCN24-1671 THE METABOLIC VULNERABILITY INDEX, REFLECTING MALNUTRITION AND INFLAMMATION, PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS	24
WCN24-2081 ATYPICAL MANIFESTATION OF TUBERCULOSIS IN HEMODIALYSIS	24
WCN24-2180 The beneficial effects of ω3-PUFA on renal fibrosis via AMPK-mediated autophagy flux	24
WCN24-2225 COMPARISON OF HANDHELD VERSUS HIGH-END ULTRASOUND DEVICES FOR THE GUIDANCE OF PERCUTANEOUS KIDNEY BIOPSY	24
WCN24-594 REMOTE MONITORING: WHAT REALLY HAPPENS DURING PERITONEAL DIALYSIS?	24
WCN24-2135 CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT IN CHILDREN IN TWO HOSPITALS IN DOUALA CAMEROON	23
WCN24-295 COVID-19 AND ACUTE KIDNEY INJURY IN ELDERLY PATIENTS: COMPARATIVE COHORT STUDY BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC IN BRAZIL	23
WCN24-2576 ENHACING SAFETY IN TUNNELED HEMODIALYSIS CATHETER INSERTION WITH NON-FLUOROSCOPIC TECHNIQUES	23
WCN24-2452 A STUDY OF CLINICAL PROFILE AND OUTCOME OF PREGNANCY RELATED ACUTE KIDNEY INJURY IN A TERTIARY CARE CENTER IN SOUTH INDIA	23
WCN24-2671 ORCHESTRA (Korean dialysis cohort for mineral, vascular calcification, and fracture) Study: Design, method, and baseline characteristics	23
WCN24-797 Roles of Irisin, a myokine on uremic sarcopenia	23
WCN24-1234 RENAL TUBULE-SPECIFIC NRF2 DELETION ATTENUATES GLOMERULAR HYPERFILTRATION AND KIDNEY INJURY VIA DOWN-REGULATION OF SGLT2 AND ANGIOTENSINOGEN EXPRESSION IN DIABETIC MICE	23
WCN24-2404 THROMBOTIC MICROANGIOPATHY AS CAUSE OF RENAL GRAFT DYSFUNCTION IN PATIENT WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS AND RESPONSE TO B-CELL ACTIVATING FACTOR I	23
WCN24-741 LONG-TERM OUTCOMES OF RENAL TRANSPLANTATION IN CHILDREN WEIGHING LESS THAN 10 KG	23
WCN24-455 COMMUNITY HEALTH WORKERS AND CHRONIC KIDNEY DISEASE: A GLOBAL PERSPECTIVE	23
WCN24-861 SUBCLINICAL RHABDOMYOLYSIS IN MESOAMERICAN NEPHROPATHY	22
WCN24-1041 OXIRIS MEMBRANE PERFORMANCE IN PATIENTS WITH SEPTIC SHOCK AND CONTINUOUS KIDNEY REPLACEMENT THERAPY REQUIREMENT: A RANDOMIZED CONTROLLED TRIAL	22
WCN24-2440 A PROSPECTIVE STUDY OF ROLE OF" DOUBLE J STENTING" IN UROSEPSIS, PROGRESSING TO SEVERE SEPPSIS IN A TERITIARY CARE CENTER IN RURAL INDIA	22
WCN24-2260 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS	22
WCN24-2134 TG/HDL-C ratio as mortality predictor in chronic hemodialysis patients	22
WCN24-496 THE SIGNIFICANCE OF DETERMINING IMMUNO-NUTRITIONAL INDEXES IN THE ASSESSMENT OF LUPUS NEPHRITIS ACTIVITY	21
WCN25-1583 PREVALENCE AND RISK FACTORS OF INTRADIALYTIC HYPERTENSION IN MALAYSIAN HAEMODIALYSIS PATIENTS: A MUTLI-CENTRE OBSERVATIONAL STUDY	21
WCN25-992 STRATEGIES TO DECREASE HEPATITIS C BURDEN AND IMPROVE SAFETY, COST-EFFECTIVELY IN THE HEALTH SYSTEM AMONG PATIENTS ON HEMODIALYSIS: LESSONS FROM LOW RESOURCE SETTINGS	21
WCN25-3072 CLINICAL FEATURES OF 7 PATIENTS UNDER HEMODIALYSIS FOR MORE THAN 20 YEARS IN THE DIALYSIS UNIT OF THE UNIVERSITY HOSPITAL CENTRE OF SAHLOUL	21
WCN25-1290 A FATAL CASE OF AV FISTULA THROMBOSIS ASSOCIATED WITH PULMONARY THROMBOEMBOLISM IN POST RENAL TRANSPLANT PATIENT	21
WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients	21
WCN25-3057 Environmentally Informed Prescribing in Kidney Care: An environmental impact scan of a provincial kidney formulary	21
WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY	21
WCN25-2239 QUANTITATIVE IMAGE ANALYSIS UNCOVERS THE EFFICACY OF THE SELECTIVE ENDOTHELIN A RECEPTOR ANTAGONIST ATRASENTAN IN A RAT MODEL OF IGA NEPHROPATHY	21
WCN25-4221 DEMOGRAPHY AND PRACTICE PATTERN OF END STAGE RENAL DISEASE IN KERALA,INDIA-REPORT FROM TRIVANDRUM DIALYSIS REGISTRY BY TRIVANDRUM NEPHROLOGY CLUB	20
WCN25-967 REGULAR USE OF TACROLIMUS GENOTYPE TEST AND USE OF FLUCONAZOLE IN FAST METABOLIZERS TO ACHIVE THERAPEUTIC DRUG LEVELS POST KIDNET TRANSPLANTATION	20
WCN25-1020 Nephrology as the leader in Point of Care Ultrasound (POCUS)	20
WCN25-1896 ONE YEAR OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS IN ZAMBIA - SUBSAHARAN AFRICA	20
WCN25-414 EFFECT OF STRUCTURED NUTRITIONAL EDUCATION ON SUBJECTIVE GLOBAL ASSESSMENT SCORES IN HAEMODIALYSIS PATIENTS: A SINGLE CENTRE –PROSPECTIVE OBSERVATIONAL STUDY	20
WCN25-4456 GLOMERULOCYSTIC KIDNEY DISEASE: KEY INSIGHTS AND LESSONS LEARNED	20
WCN25-3847 AN UNUSUAL CASE OF HSV PNEUMONIA MASQUERADING AS PCP PNEUMONIA IN POST TRANSPLANT PATIENT	20
WCN25-4542 Virtual Care is a barrier to sustaining trusting relationships and optimal clinical outcomes for Peritoneal Dialysis patients from Rural and Indigenous Communities	20
WCN25-3972 THE SILENT THREAT: CAN BATTERIES DISCHARGE YOUR KIDNEYS? – A CASE REPORT ON AKI DUE TO OCCUPATIONAL EXPOSURE	20
WCN25-643 THE LIFESAVING JOURNEY FOR CALCIPHYLAXIS: ADDRESSING RAPIDLY PROGRESSIVE ATTACKS WITH MULTIDIMENSIONAL AND AI RESEARCH FOR REGENERATIVE MEDICINE	20
WCN25-2130 A STUDY TO CORRELATE SERUM PHOSPHORUS WITH MARKER OF ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HAEMODIALYSIS	19
WCN25-989 Challenges and Opportunities in Assessing Kidney Function in Simultaneous Heart-Kidney Transplant Candidates	19
Corrigendum to “WCN24-2221 NEPHROCALCINOSIS AND LOWER LIMBS TISSUE NECROSIS DUE TO CALCIUM OXALATE DEPOSITS IN A 24-YEAR-OLD PATIENT WITH STAGE 5 CHRONIC KIDNEY DISEASE” [Kidney International Reports	19
Corrigendum to “Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy” [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]	19
WCN25-4220 CAPD IN ESRD AND CLD PATIENTS WITH REFRACTORY ASCITES: A 12-MONTH FOLLOW-UP STUDY	19
WCN25-3276 SPECTRUM OF KIDNEY DISEASES IN ADOLESCENT POPULATION: A SINGLE-CENTER STUDY	19
WCN25-2785 UNMET MENTAL HEALTH NEEDS AND CAREGIVER STRAIN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS	19
Corrigendum to “Clinicopathological Characteristics of Adult IgA Nephropathy in the United States” [Kidney International Reports Volume 8, Issue 9, September 2023, Pages 1792-1800]	19
WCN23-0595 A MIN-TERM CLINICAL FOLLOW-UP STUDY ON CREATING ARTEIOVENOUS FISTULA BY A MODIFIED NO-TOUCH TECHNIQUE	19
WCN25-2982 USG guided needle directed thrombolysis of acute AVF thrombosis: A Case Series	19
WCN25-4606 DIAGNOSTIC UTILITY AND CLINICAL IMPACT OF GENOMIC TESTING NI ADOLESCENT AND ADULT KIDNEY DISEASE PATIENTS WITH SUSPECTED MONOGENIC ETIOLOGY – A PRAGMATIC PROSPECTIVE OBSERVATIONAL COHORT ST	19
WCN25-1541 Comparing the Accuracy of Overhydration Assessment Methods in Hemodialysis and Peritoneal Dialysis Patients: The Potential Future of Wearable BIA Device	19
Erratum to “Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919	19
WCN25-4378 OUTCOME OF USE OF ENTERIC RELEASED BUDESONIDE IN IgA NEPHROPATHY PATIENTS WITH NEPHROTIC AND SUBNEPHROTIC PROTEINURIA PRESENTATIONS: PROSPECTIVE COMPARATIVE STUDY IN TERTIARY CARE CENTRE	19
Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation	18
WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY	18
WCN24-1204 MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY	18
WCN25-128 SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS: SHORT- AND LONG-TERM OUTCOMES OF CONSERVATIVE PARATHYROIDECTOMY	18
WCN25-3004 ANTi-NEPHRIN ANTIBODIES IN A LARGE COHORT OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME	18
WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY	18
In-Center Hemodialysis and Patient Travel Time in Aotearoa New Zealand: A Nationwide Geospatial and Data Linkage Study	18
Vasopressin for Post-kidney Transplant Hypotension	18
WCN25-3017 IMMUNOSUPPRESSION COMBINED WITH TONSILLECTOMY IS EFFECTIVE IN CAUCASIAN PATIENTS WITH HIGH-RISK PRIMARY IGA-NEPHROPATHY	18
Coronaries, Calcium, and Kidney Consequences	18
POS-237 Prevalence and risk factors of anemia among non-dialysis chronic kidney disease patients: a single-centre, cross-sectional study from Malaysia	18
WCN25-1682 STUDY OF MEAN PLATELET VOLUME AND RED CELL DISTRIBUTION WIDTH IN ACUTE KIDNEY INJURY	18
WCN25-2084 EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS	18
WCN25-2338 POTENTIAL DIAGNOSTIC ROLE OF URINARY EXOSOMAL miRNAS IN IgA NEPHROPATHY: A CLINICAL OBSERVATIONAL STUDY	18

Use of Glucose-Lowering Agents in Diabetes and CKD	18
Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection	17
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab	17
Feasibility of DNA-Based Diagnosis of Fibrinogen A Alpha-Chain Amyloidosis From Paraffin-Embedded Kidney Tissue	17
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease	17
Higher Symptom Frequency and Severity After the Long Interdialytic Interval in Patients on Maintenance Intermittent Hemodialysis	17
WCN25-4586 Microbiological Evaluation of Urinary samples in A Cohort of Patients with Chronic Kidney Disease: A descriptive study	17
Ecological Momentary Assessment to Explore Fatigue, Mood, and Physical Activity Levels in People Receiving Peritoneal Dialysis	17
Risks, Diagnostic Thresholds, and Outcomes of Pediatric CKD in Rural Africa	17
Clinicopathologic Features of IgG4-Related Kidney Disease	17
Canadian Stakeholders’ Perspectives on Voucher Donation in Kidney Transplantation	17
Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada	17
Dissecting the Obesity Paradox in Patients With Obesity and CKD	16
POS-486 SECONDARY POLYCYTHEMIA IN NEPHROTIC SYNDROME – AN UNCOMMON ASSOCIATION	16
POS-872 Post covid vaccination- new onset glomerulonephritis- a mere co incidence or a impending reality??	16
Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist	16
POS-187 PROGNOSTIC ROLES OF URINARY TUBULAR INJURY MARKERS IN DIABETIC NEPHROPATHY	16
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD	16
Inside CKD: Cost-Effectiveness of Multinational Screening for CKD	16
WCN23-0427 COENZYME Q10 SUPPLEMENTATION IN AN ADULT PATIENT WITH COQ8 MUTATION AND NEPHROTIC SYNDROME ALLEVIATES RENAL FUNCTION DETERIORATION AND REMITS PROTEINURIA	16
Oxidative Stress Contributes to Slit Diaphragm Defects Caused by Disruption of Endocytosis	16
Early Identification of CKD—A Scoping Review of the Global Populations	16
High Macrophage Densities in Native Kidney Biopsies Correlate With Renal Dysfunction and Promote ESRD	16
Exploring Preconceptions as Barriers to Peritoneal Dialysis Eligibility: A Global Scenario-Based Survey of Kidney Care Physicians	16
Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy	16
Clinical Real-Time Genome Sequencing to Solve the Complex and Confounded Presentation of a Child With Focal Segmental Glomerulosclerosis and Multiple Malignancies	16
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD	16
Population Frequency of Undiagnosed Fabry Disease in the General Population	15
Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories	15
POS-652 THE DIRECT COST OF DIALYSIS IN SRI LANKA	15
Metabolic Acidosis Is Associated With an Accelerated Decline of Allograft Function in Pediatric Kidney Transplantation	15
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients	15
Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?	15
Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”	15
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health	15
Droxidopa for Management of Chronic Hypotension in Hemodialysis	15
WCN24-933 Effectiveness and safety of Finerenone in Chinese CKD patients without diabetes mellitus: A real-world retrospective study	15
All About ABBA: New Insights Into Antibrush Border Antibody Disease	15
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study	15
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial	15
Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective	15
WCN23-0373 ALTERNATIVE COMPLEMENT PATHWAY PHARMACODYNAMICS OF IPTACOPAN	15
Fertility Management in Cystinosis: A Clinical Perspective	15
WCN24-788 IGA GLOMERULONEPHRITIS, RENAL CORTICAL NECROSIS AND A SYSTEMIC AUTOINFLAMMATORY DISEASE: COINCIDENCE OR CAUSATION? A CASE REPORT	14
WCN24-1712 EPIDEMIOLOGICAL ANALYSIS OF MORTALITY FROM URINARY TRACT MALIGNANT NEOPLASM IN BRAZIL, 2010 - 2020	14
Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti–CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study	14
POS-153 COLLAPSING GLOMERULOPATHY IN A FILIPINO FEMALE PRESENTING WITH NEPHROTIC SYNDROME POST-PARTUM	14
POS-743 POTENTIAL OF QUALITY OF LIFE EVALUATION THROUGH PERVASIVE SENSING TECHNOLOGY IN HOME DIALYSIS THERAPY	14
WCN23-0270 ASSOCIATION OF HEMOPERFUSION DISEASE PROGRESSION AMONG PATIENTS WITH SEVERE-TO-CRITICAL COVID-19	14
Cost-Minimization Analysis of Tolvaptan Treatment for ADPKD in Southern Spain	14
WCN24-1687 Factors associated with partial or total recovery of renal function in patients with AKI KDIGO 3 at the ISSEMyM Medical Center who required replacement therapy	14
WCN24-1323 TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA	14
POS-073 BUILDING A PREDICTION MODEL FOR POSTOPERATIVE ACUTE KIDNEY INJURY USING MACHINE LEARNING	14
WCN23-1022 Persistent microscopic hematuria in IgA nephropathy and frequency of gross hematuria following SARS-CoV-2 mRNA vaccination	14
POS-241 FRAILTY: COROLLARY OR CAUSALITY OF MALNUTRITION	14
WCN25-79 NON-INVASIVE DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY MACHINE-LEARNING BASED EVALUATION OF URINARY EXFOLIATED PROXIMAL TUBULE CELL MULTISPECTRAL AUTOFLUORESCENCE	14
WCN24-2140 KNOWLEDGE, AWARENESS AND ATTITUDE TOWARDS ORGAN DONATION AMONG GENERAL POPULATION IN INDIA: A SINGLE CENTRE EXPERIENCE	14
WCN24-904 ASSOCIATION BETWEEN THE NEED FOR RENAL REPLACEMENT THERAPY AND IN-HOSPITAL MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION	14
POS-688 FRAILTY RATE OF PERITONEAL DIALYSIS PATIENTS: A META-ANALYSIS	14
WCN23-1218 ANALYSIS OF GRAFT SURVIVAL: 14 YEARS OF EXPERIENCE IN A DOMINICAN TRANSPLANT PROGRAM	14
POS-281 ASSOCIATION BETWEEN AMBIENT PM1 AND THE PREVALENCE OF CHRONIC KIDNEY DISEASE IN CHINA: A NATIONWIDE STUDY	13
WCN23-0353 RENAL BIOPSY REGISTRY FROM A SINGLE CENTRE IN INDIA: 20 YEARS EXPERIENCE	13
POS-067 TUBULAR CELL POLYPLOIDY IS LIFESAVING AFTER ACUTE KIDNEY INJURY AND A TARGET TO PREVENT CHRONIC KIDNEY DISEASE	13
POS-139 SIGNIFICANT REDUCTION IN MORBIDITY FROM RECURRENT URINARY TRACT INFECTIONS IN RENAL TRANSPLANT PATIENTS WITH CONVENIENT ORAL ANTISEPTIC METHENAMINE HIPPURATE	13
WCN23-0420 EPIDEMIOLOGY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTER RETROSPECTIVE COHORT	13
POS-038 SURVIVAL OUTCOME IN PATIENTS DIAGNOSED MULTIPLE MYELOMA WITH RENAL IMPAIRMENT: A RETROSPECTIVE STUDY OF 53 PATIENTS	13
WCN23-0185 THE SURFACER® INSIDE-OUT ACCESS CATHETER SYSTEM IN A HEMODIALYSIS PATIENT WITH PREVIOUS VASCULAR ACCESS COMPLICATIONS-CASE REPORT	13
POS-671 PATIENTS WITH POLYCYSTIC KIDNEY DISEASE ON PERITONEAL DIALYSIS: A SINGLE CENTRE TERTIARY CARE RENAL UNIT EXPERIENCE FROM UNITED KINGDOM	13
WCN23-0722 EFFECT OF HYPOXIA/REOXYGENATION INJURY ON P-GP IN RENAL TUBULAR CELLS ANG ITS REGULATION	13
WCN23-0106 IN-VIVO PHOSPHATE REDUCTION: LANTHANUM DIOXYCARBONATE VS LANTHANUM CARBONATE TETRAHYDRATE	13
POS-021 C4 COMPLEMENT DEFICIENCY AND TYPE III CRYOGLOBUINEMIA IN A PATIENT WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	13
WCN23-1145 A COMPARATIVE LONG TERM OUTCOME STUDY OF DIFFUSE CRESCENTIC IMMUNOGLOBULIN A NEPHROPATHY AND ANCA ASSOCIATED PAUCIMMUNE CRESCENTIC GLOMERULONEPHRITIS	13
POS-734 POST DIALYSIS FATIGUE IN HEMODIALYSIS (HD) PATIENTS: PIPER FATIGUE SCALE	13
POS-638 PREVALENCE AND PROFILE OF PULMONARY HYPERTENSION AND RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS ON HEMODIALYSIS IN INDIA	13
POS-144 SERONEGATIVE ANTI GBM GLOMERULONPEHRITIS	13
WCN23-0474 EVOLUTION OF VASCULAR ACCESS IN HEMODIALYSIS	13
WCN23-0634 USE OF HERBAL MEDICINE IN CHRONIC HAEMODIALYSIS PATIENTS	13
POS-535 HUMAN LEUKOCYTE ANTIGEN (HLA) IN KIDNEY TRANSPLANT RECIPIENTS WITH COVID-19 EXPERIENCE OF NEPHROLOGY DEPARTMENT OF SAHLOUL HOSPITAL	13
WCN23-0692 Identification of hub biomarkers and therapeutic agents for renal interstitial fibrosis through bioinformatics analysis and experimental validation	13
POS-979 EFFICACY AND SAFETY OF RITUXIMAB IN COMPLICATED STEROID DEPENDENT AND REFRACTORY STEROID RESISTANT CHILDHOOD NEPHROTIC SYNDROME	13
POS-821 TO STUDY THE ASSOCIATION OF SERUM VITAMIN D WITH POST -TRANSPLANT DIABETES MELLITUS (PTDM) IN KIDNEY TRANSPLANT RECIPIENTS IN INDIAN SETTINGS	13
WCN23-0352 TO STUDY THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS OF CKD WITH AND WITHOUT TYPE 2 DIABETES MELLITUS	13
POS-731 INFLUENCING FACTORS FOR RESIDUAL KIDNEY FUNCTION IN INCIDENT PERITONEAL DIALYSIS PATIENTS: A META-ANALYSIS OF OBSERVATIONAL STUDIES	13
POS-977 RISK OF COVID-19 INFECTION POST VACCINATION PROGRAMME IN PATIENTS WITH END STAGE KIDNEY DISEASE IN PENANG STATE	13
POS-717 CLINICAL AND PROGNOSTIC RELEVANCE OF OMENTIN-1 IN NEW PERITONEAL DIALYSIS PATIENTS	13
POS-633 SEVERE ACIDOSIS AND RELATIONSHIP WITH MUSCLE CRAMPS IN HEMODIALYSIS PATIENTS: A SINGLE-CENTER STUDY	13
POS-616 RISK FACTORS OF AVF COMPLICATIONS	13
POS-098 MILKY URINE IN RENAL ALLOGRAFT RECIPIENT - CAN NATIVE KIDNEY BE THE CULPRIT ?	13
WCN23-0041 THE RENAL BENEFITS OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS MUST BE ASSESSED BASED ON A STANDARDISED DEFINITION OF RENAL COMPOSITE OUTCOMES: A META-ANALYSIS	13
WCN23-0683 CLINICAL AND HISTOPATHOLOGICAL PROFILE OF SIX LUPUS NEPHRITIS CASES AT A TERTIARY REFERRAL CENTRE IN DAR-ES-SALAAM, TANZANIA	13
WCN23-0281 KIDNEY TRANSCRIPTOMICS PATTERNS PREDICT RAPID PROGRESSION OF DIABETIC KIDNEY DISEASE	13
WCN23-0413 COMPARISON OF RISK FACTORS, CLINICAL CHARACTERISTICS AND SHORT-TERM CLINICAL OUTCOME OF URINARY TRACT INFECTIONS IN CHILDREN CAUSED BY NON- ESBL AND ESBL PRODUCING BACTERIA	13
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria	12
POS-132 TRIAL DESIGN: PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NARSOPLIMAB SAFETY AND EFFICACY IN IGA NEPHROPATHY (ARTEMIS-IGAN)	12
Response to the Letter to the Editor Entitled “The Context of Kidney Care in Pacific Island Countries”	12